HCW Biologics Inc. (HCWB): Price and Financial Metrics
HCWB Price/Volume Stats
| Current price | $0.95 | 52-week high | $2.52 |
| Prev. close | $1.10 | 52-week low | $0.28 |
| Day low | $0.81 | Volume | 7,511,700 |
| Day high | $1.11 | Avg. volume | 2,595,005 |
| 50-day MA | $0.52 | Dividend yield | N/A |
| 200-day MA | $0.93 | Market Cap | 35.83M |
HCWB Stock Price Chart Interactive Chart >
HCW Biologics Inc. (HCWB) Company Bio
HCW Biologics Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company is involved in developing HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. It is also developing HCW9218 as an injectable immunotherapeutic for patients with pancreatic, breast, ovarian, colorectal, and prostate cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
HCWB Price Returns
| 1-mo | 71.17% |
| 3-mo | 102.13% |
| 6-mo | -14.41% |
| 1-year | -14.03% |
| 3-year | -64.55% |
| 5-year | N/A |
| YTD | -22.45% |
| 2023 | -36.02% |
| 2022 | -17.47% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...